Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

UNIVERSITY OF WASHINGTON

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1861-01-01

Employees: 10K

Market Cap: -

Website: https://www.cs.washington.edu

Clinical Trials

The Effect of Exercise on Mood After Traumatic Brain Injury

Not Applicable

Completed

Conditions: Depression
Traumatic Brain Injury

Interventions: Behavioral: Aerobic exercise
Behavioral: No exercise

First Posted Date: 2007-12-12

Last Posted Date: 2017-02-06

Lead Sponsor: University of Washington

Target Recruit Count: 78

Registration Number: NCT00571545

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Phase 2

Completed

Conditions: Malignant Pleural Effusion
Stage IIIB Non-small Cell Lung Cancer
Stage IV Non-small Cell Lung Cancer

Interventions: Drug: carboplatin
Drug: docetaxel
Drug: gemcitabine hydrochloride
Drug: paclitaxel
Procedure: computed tomography
Procedure: positron emission tomography
Radiation: fludeoxyglucose F 18
Other: imaging biomarker analysis

First Posted Date: 2007-11-28

Last Posted Date: 2017-02-10

Lead Sponsor: University of Washington

Target Recruit Count: 55

Registration Number: NCT00564733

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States
🇺🇸
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium, Seattle, Washington, United States

Pre-Exposure Prophylaxis to Prevent HIV-1 Acquisition Within HIV-1 Discordant Couples

Phase 3

Completed

Conditions: HIV-1 Infections
HIV Infections

Interventions: Drug: Tenofovir Disoproxil Fumarate (TDF)
Drug: Emtricitabine/Tenofovir Disoproxil Fumarate (FTC/TDF)
Drug: Placebo

First Posted Date: 2007-11-12

Last Posted Date: 2019-04-19

Lead Sponsor: University of Washington

Target Recruit Count: 4758

Registration Number: NCT00557245

Locations: 🇰🇪
Moi University - Indiana University, Eldoret, Kenya
🇰🇪
CMR, Kemri-UCSF, Kisumu, Kenya
🇰🇪
Kenyatta National Hospital/University of Nairobi, Nairobi, Kenya

and more 6 locations

Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease

Phase 2

Completed

Conditions: Diabetes Mellitus
Chronic Kidney Disease
Diabetic Kidney Disease

Interventions: Dietary Supplement: Cholecalciferol
Dietary Supplement: Placebo

First Posted Date: 2007-11-01

Last Posted Date: 2014-04-28

Lead Sponsor: University of Washington

Target Recruit Count: 22

Registration Number: NCT00552409

Locations: 🇺🇸
University of Washington, Seattle, Washington, United States

Bacterial Vaginosis; A Randomized Trial to Reduce Recurrence

Not Applicable

Completed

Conditions: Bacterial Vaginosis

Interventions: Other: hygienic information plus 62% ethyl alcohol in emollient gel
Other: hygienic information

First Posted Date: 2007-10-10

Last Posted Date: 2007-10-31

Lead Sponsor: University of Washington

Target Recruit Count: 223

Registration Number: NCT00542074

Locations: 🇰🇪
Nairobi City Council STI referral clinic (Special Treatment Clinic), Nairobi, Kenya

Automated Real-time Feedback on CPR Study

Phase 2

Completed

Conditions: Heart Arrest

Interventions: Other: Laerdal Q-CPR /technology

First Posted Date: 2007-10-04

Last Posted Date: 2012-06-25

Lead Sponsor: University of Washington

Target Recruit Count: 1586

Registration Number: NCT00539539

Locations: 🇺🇸
University of Pittsburgh, Pittsburgh, Pennsylvania, United States
🇺🇸
University of Washington, Seattle, Washington, United States
🇨🇦
The Ottawa Hospital, Thunder Bay, Ontario, Canada

Hormone and Information Processing Study

Phase 3

Completed

Conditions: Mild Cognitive Impairment
Alzheimer's Disease

Interventions: Drug: testosterone gel
Drug: placebo gel

First Posted Date: 2007-10-04

Last Posted Date: 2014-07-14

Lead Sponsor: University of Washington

Target Recruit Count: 22

Registration Number: NCT00539305

Locations: 🇺🇸
VA Puget Sound Health Care Systems, Seattle, Washington, United States

HSV-2 Suppression to Reduce Maternal HIV-1 RNA Levels During Pregnancy and Breastfeeding

Phase 2

Completed

Conditions: HIV Infections
Herpes Simplex

Interventions: Drug: valacyclovir
Drug: placebo

First Posted Date: 2007-09-17

Last Posted Date: 2018-12-19

Lead Sponsor: University of Washington

Target Recruit Count: 148

Registration Number: NCT00530777

Locations: 🇰🇪
Mathare North City Clinic, Nairobi, Kenya

Trial to Study the Effect of Dose of Herpes Simplex Virus-2 (HSV-2) Suppressive Therapy on HSV and HIV

Phase 4

Completed

Conditions: HIV Infection
Genital Herpes

Interventions: Drug: valacyclovir
Drug: acyclovir

First Posted Date: 2007-09-11

Last Posted Date: 2018-06-07

Lead Sponsor: University of Washington

Target Recruit Count: 28

Registration Number: NCT00527618

Locations: 🇺🇸
University of Washington Virology Research Clinic, Seattle, Washington, United States

Transcranial Magnetic Stimulation for Treating Women With Chronic Widespread Pain

Phase 2

Completed

Conditions: Fibromyalgia
Chronic Pain
Depression

Interventions: Device: rTMS
Device: Sham rTMS

First Posted Date: 2007-09-03

Last Posted Date: 2013-05-23

Lead Sponsor: University of Washington

Target Recruit Count: 19

Registration Number: NCT00524420

Locations: 🇺🇸
Harborview Medical Center, Seattle, Washington, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy